The spectrum of skin diseases in four different types of organ-transplant recipients: a comparative single-centre cohort study.


Journal

European journal of dermatology : EJD
ISSN: 1952-4013
Titre abrégé: Eur J Dermatol
Pays: France
ID NLM: 9206420

Informations de publication

Date de publication:
01 Feb 2021
Historique:
pubmed: 3 3 2021
medline: 5 11 2021
entrez: 2 3 2021
Statut: ppublish

Résumé

Organ transplant recipients (OTR) are at marked increased risk of skin cancer and skin infections compared to the general population. The purpose of this study was to acquire long-term incidence data on commonly occurring skin diseases in four different transplant groups. This retrospective single-centre cohort study included 621 OTR. By counting defined malignant, inflammatory, infectious or drug-related skin conditions per patient and visit, incidence rates (IR) for the different groups of OTR were calculated as cases per 1000-patient years and cumulative incidences of non-melanoma skin cancer (NMSC), respectively. Overall, 2,309 non-malignant skin conditions and 340 NMSC were registered. Skin infections were most common (51.4%), followed by inflammatory skin conditions (35.6%) and sun-induced skin damage (32.9%). Kidney transplant recipients (KTR) had a 4.7-fold (95% CI: 2.7-8.0; p < 0.0001), 2.6-fold (95% CI: 1.2-5.3; p = 0.0098) and 5.4-fold (95% CI: 2.8-10.3; - < 0.0001) higher IR for oral candidiasis, oral aphthosis and herpes simplex virus infections, respectively, compared to the other OTR. Pruritus was most commonly reported in liver transplant recipients (95% CI: 1.3-5.3; p = 0.0047). KTR and lung transplant recipients (LuTR) had a 10.7-fold (95% CI:3.6-43.2; p < 0.0001) higher IR of steroid induced acne. KTR had a 1.6-fold (95% CI: 1.1-2.3; p = 0.0096) higher IR of squamous cell carcinoma compared to the other groups. The incidence of basal cell carcinoma was 2.5-fold higher (95% CI: 1.7-3.6; p < 0.0001) in LuTR, compared to the other OTR. This study provides additional organ-specific incidence data on non-malignant skin diseases and skin cancer in OTR.

Sections du résumé

BACKGROUND BACKGROUND
Organ transplant recipients (OTR) are at marked increased risk of skin cancer and skin infections compared to the general population.
OBJECTIVES OBJECTIVE
The purpose of this study was to acquire long-term incidence data on commonly occurring skin diseases in four different transplant groups.
MATERIALS & METHODS METHODS
This retrospective single-centre cohort study included 621 OTR. By counting defined malignant, inflammatory, infectious or drug-related skin conditions per patient and visit, incidence rates (IR) for the different groups of OTR were calculated as cases per 1000-patient years and cumulative incidences of non-melanoma skin cancer (NMSC), respectively.
RESULTS RESULTS
Overall, 2,309 non-malignant skin conditions and 340 NMSC were registered. Skin infections were most common (51.4%), followed by inflammatory skin conditions (35.6%) and sun-induced skin damage (32.9%). Kidney transplant recipients (KTR) had a 4.7-fold (95% CI: 2.7-8.0; p < 0.0001), 2.6-fold (95% CI: 1.2-5.3; p = 0.0098) and 5.4-fold (95% CI: 2.8-10.3; - < 0.0001) higher IR for oral candidiasis, oral aphthosis and herpes simplex virus infections, respectively, compared to the other OTR. Pruritus was most commonly reported in liver transplant recipients (95% CI: 1.3-5.3; p = 0.0047). KTR and lung transplant recipients (LuTR) had a 10.7-fold (95% CI:3.6-43.2; p < 0.0001) higher IR of steroid induced acne. KTR had a 1.6-fold (95% CI: 1.1-2.3; p = 0.0096) higher IR of squamous cell carcinoma compared to the other groups. The incidence of basal cell carcinoma was 2.5-fold higher (95% CI: 1.7-3.6; p < 0.0001) in LuTR, compared to the other OTR.
CONCLUSION CONCLUSIONS
This study provides additional organ-specific incidence data on non-malignant skin diseases and skin cancer in OTR.

Identifiants

pubmed: 33648926
pii: ejd.2021.3967
doi: 10.1684/ejd.2021.3967
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

65-74

Auteurs

Liliane Borik-Heil (L)

Department of Dermatology, Medical University of Vienna, Austria.

Angelika Geroldinger (A)

Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, AustriaArticle accepted on July 16, 2020.

Daniela Dunkler (D)

Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, AustriaArticle accepted on July 16, 2020.

Alexandra Geusau (A)

Department of Dermatology, Medical University of Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH